Anthony Hunt, Chief Executive Officer at REPLIGEN CORP (RGEN), sold 17,742 shares at $188.06 ($3.4M) on 2021-03-12, disclosed to the SEC on 2021-03-12.
Seasonal sale ($3.4M) by Chief Executive Officer — this insider has traded RGEN in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $188.06 | 914 | $172K | 5.1% |
| 2 | $188.06 | 914 | $172K | 5.1% |
| 3 | $188.77 | 1,171 | $221K | 6.5% |
| 4 | $188.77 | 1,171 | $221K | 6.5% |
| 5 | $190.17 | 4,096 | $779K | 23.1% |
| 6 | $190.17 | 4,096 |
| $779K |
| 23.1% |
| 7 | $191.19 | 1,081 | $207K | 6.1% |
| 8 | $191.19 | 1,081 | $207K | 6.1% |
| 9 | $192.17 | 1,378 | $265K | 7.8% |
| 10 | $192.17 | 1,378 | $265K | 7.8% |
| 11 | $193.30 | 227 | $44K | 1.3% |
| 12 | $194.08 | 235 | $46K | 1.4% |
| Total | $190.29 avg | 17,742 | $3.4M | 100% |
| Filing → |
| RGEN | SELL | 2025-09-11 | $7.0M | — | Filing → |
| RGEN | SELL | 2025-05-16 | $6.5M | — | Filing → |
| RGEN | SELL | 2025-03-19 | $8.1M | — | Filing → |